Cutting edge: long-term B cell memory in humans after smallpox vaccination.
about
Rapid cloning of high-affinity human monoclonal antibodies against influenza virusClonogenic multiple myeloma progenitors, stem cell properties, and drug resistanceThe Future of Smallpox Vaccination: is MVA the key?The role of research in viral disease eradication and elimination programs: lessons for malaria eradicationPrimer on the Immune SystemCytokine production associated with smallpox vaccine responsesMemory T follicular helper CD4 T cellsDynamics of the CD8 T-cell response following yellow fever virus 17D immunizationWanted, dead or alive: New viral vaccinesStructural and Biochemical Characterization of the Vaccinia Virus Envelope Protein D8 and Its Recognition by the Antibody LA5Young lives lost as B cells falter: what we are learning about antibody responses in malaria.Waning and aging of cellular immunity to Bordetella pertussisDisabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinasesChimeric virus-like particles containing influenza HA antigen and GPI-CCL28 induce long-lasting mucosal immunity against H3N2 virusesHIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogenHumoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in HumansHeterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical TrialsA gammaherpesvirus Bcl-2 ortholog blocks B cell receptor-mediated apoptosis and promotes the survival of developing B cells in vivoGenome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipientsSafety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.Ii-Key/MHC class II epitope hybrids: a strategy that enhances MHC class II epitope loading to create more potent peptide vaccines.Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic.Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years OldNeutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particlesBroadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.Mcl-1 is essential for the survival of plasma cells.UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV.Microneedle and mucosal delivery of influenza vaccines.Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses.Detection of influenza A virus homo- and heterosubtype-specific memory B-cells using a novel protein microarray-based analysis tool.Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosisRecovery of an antiviral antibody response following attrition caused by unrelated infection.Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infectionDendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo.Studies of the anti-platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens.A method for identification of HIV gp140 binding memory B cells in human blood.Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection.Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery.
P2860
Q24644672-CE24C0EA-7E61-40B0-A0C2-A303ECDF300AQ24644883-EFBB6264-B1B4-4468-9CC3-A38FE2110585Q24801195-1A1BED3D-9BCC-4CB1-99DD-3C5DEEE6E5F8Q26700366-CB9B3606-737D-424B-9971-0714CBC6DFF2Q26773202-7A4C6FE8-EBD7-438D-8839-E25A0B84E43BQ26823501-942C0DC8-30F3-49DF-AF06-BF6DA2B70B79Q26829047-9E389083-FB64-46FA-A5EA-D636A612A187Q27489813-B274ABC6-BBC4-4F68-A3EF-40ECCD82C544Q27489979-9EAE2D26-4781-4273-AA93-BB49FBC28891Q27679281-C5FCE16D-52A2-4E39-BCDC-2B8E0403F55FQ27687235-C9810C9A-55E9-4776-997D-5AD0C7E1FB2AQ28080731-8AF1EEEA-4594-4A3F-8D41-3DB074F69E6CQ28258417-B10DFE7F-8E4F-40C9-A6E2-EDAE774868CEQ28365124-A78E1AE4-8F2C-495A-8F40-24BE7F2AF4EEQ28390427-11D9CF27-A0FF-45F7-A17B-E23BA3E296E3Q28391301-2B7FF333-BAD3-44BC-87BF-D2C6D4F977CBQ28394899-FBEE4401-E9B9-487A-BF43-F343C3305D7FQ28539635-F7FEA093-AD89-49FB-9981-EA0D89D3048EQ28943252-A0E0DB49-0B33-403E-B454-EE8E552D8739Q30151079-99E471AD-A924-4AD1-A971-F4D08867DC77Q30359230-165F33B2-35D0-4311-99F9-758E5C6AB1EAQ30365337-061A7758-2BFC-4CBC-B271-49EF49789621Q30366045-30C05305-06D4-4D64-B9E3-6E830A0EAF4FQ30371419-5336FE6A-DF4B-4871-A8D2-C5442C9905BDQ30371529-99C75033-B632-4E7C-9761-B2B0D51561BEQ30390753-5EFD10A5-0A16-40CF-AA5B-0B98D5FB989BQ30398435-0D2F5E8E-FC3E-4C6C-8BA0-BE9A9094BA39Q30412677-55D6B96B-EBA8-458D-8661-499E0B036C12Q30414377-F2D75272-3E81-4404-8A4A-3F31417EB609Q30418015-1ED5E917-E942-4B78-A19A-87BFCDC6BBE1Q30427946-3BDBDD64-CA44-449E-ACEB-E763918CB67BQ30428427-320A2552-B706-46CC-93D2-0E8306B034B7Q30431538-354D40A7-9113-44F7-908F-C3C65E72F953Q31147149-0F436CCD-13F9-426B-8D46-30D00860C1ABQ33302672-8BD0E80F-7F6C-4E21-861B-348C2CC912EEQ33328336-8F4FC2EF-13EF-4F3E-A609-45E9BFB5AE34Q33385996-D8B2C1CB-6A35-46C5-B406-F94C7FBDAB59Q33394829-57E5268E-B17E-47AB-857F-76E2883F52B4Q33410222-AE3239C5-FCEF-43F7-826F-0C3BDF40ADC5Q33412190-F7A18F89-AE67-40DC-B1AD-E72CB4F45D7D
P2860
Cutting edge: long-term B cell memory in humans after smallpox vaccination.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Cutting edge: long-term B cell memory in humans after smallpox vaccination.
@en
Cutting edge: long-term B cell memory in humans after smallpox vaccination.
@nl
type
label
Cutting edge: long-term B cell memory in humans after smallpox vaccination.
@en
Cutting edge: long-term B cell memory in humans after smallpox vaccination.
@nl
prefLabel
Cutting edge: long-term B cell memory in humans after smallpox vaccination.
@en
Cutting edge: long-term B cell memory in humans after smallpox vaccination.
@nl
P2093
P1476
Cutting edge: long-term B cell memory in humans after smallpox vaccination.
@en
P2093
Huw Davies
John Glidewell
Luis Villarreal
Phil Felgner
Rafi Ahmed
Shane Crotty
P304
P356
10.4049/JIMMUNOL.171.10.4969
P407
P577
2003-11-01T00:00:00Z